Compare IOVA & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | UPBD |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 1.1B |
| IPO Year | N/A | 1995 |
| Metric | IOVA | UPBD |
|---|---|---|
| Price | $2.39 | $19.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | $10.45 | ★ $32.25 |
| AVG Volume (30 Days) | ★ 12.6M | 769.6K |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 7.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.45 |
| Revenue | $250,425,000.00 | ★ $4,577,844,000.00 |
| Revenue This Year | $60.71 | $10.45 |
| Revenue Next Year | $59.52 | $8.03 |
| P/E Ratio | ★ N/A | $13.58 |
| Revenue Growth | ★ 175.62 | 7.48 |
| 52 Week Low | $1.64 | $15.82 |
| 52 Week High | $6.50 | $30.62 |
| Indicator | IOVA | UPBD |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 59.15 |
| Support Level | $2.29 | $17.36 |
| Resistance Level | $2.80 | $20.08 |
| Average True Range (ATR) | 0.18 | 0.75 |
| MACD | -0.05 | 0.25 |
| Stochastic Oscillator | 13.57 | 77.05 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.